贝恩资本支持的医疗技术公司Heartflow（股票代码：HTFL）今日在纳斯达克首次亮相，股价表现强劲，盘中大涨47.37%，引起市场广泛关注。
据悉，Heartflow于周四晚间以每股19美元的价格发行1,670万股股票，募集资金总额达3.167亿美元。公司此次IPO定价高于此前17美元至18美元的预期区间，反映出投资者对该公司的强烈兴趣。今日开盘价为25美元，较发行价大幅上涨，显示出市场对Heartflow的热烈追捧。
Heartflow成立于2007年，原名为Cardiovascular Simulation，专注于开发人工智能产品，用于帮助医生诊断和治疗心脏病。公司的成功上市标志着其在医疗科技领域的领先地位，也反映了投资者对AI在医疗领域应用前景的看好。作为近一个月内在纽约上市的第三家大型医疗科技公司，Heartflow的表现或将为同类企业的未来融资铺平道路。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.